Zevra Therapeutics Statistics
Total Valuation
ZVRA has a market cap or net worth of $409.93 million. The enterprise value is $380.48 million.
Important Dates
The next estimated earnings date is Thursday, March 27, 2025, after market close.
| Earnings Date | Mar 27, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ZVRA has 53.38 million shares outstanding. The number of shares has increased by 23.73% in one year.
| Current Share Class | 53.38M |
| Shares Outstanding | 53.38M |
| Shares Change (YoY) | +23.73% |
| Shares Change (QoQ) | +14.10% |
| Owned by Insiders (%) | 6.68% |
| Owned by Institutions (%) | 49.21% |
| Float | 42.00M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 1,340.51 |
| PS Ratio | 13.35 |
| Forward PS | 5.68 |
| PB Ratio | 5.86 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 15.54 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.88, with a Debt / Equity ratio of 0.86.
| Current Ratio | 2.88 |
| Quick Ratio | 2.82 |
| Debt / Equity | 0.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -14.67 |
Financial Efficiency
Return on equity (ROE) is -130.67% and return on invested capital (ROIC) is -44.81%.
| Return on Equity (ROE) | -130.67% |
| Return on Assets (ROA) | -32.80% |
| Return on Invested Capital (ROIC) | -44.81% |
| Return on Capital Employed (ROCE) | -55.23% |
| Revenue Per Employee | $354,913 |
| Profits Per Employee | -$1.30M |
| Employee Count | 69 |
| Asset Turnover | 0.15 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +11.47% in the last 52 weeks. The beta is 2.00, so ZVRA's price volatility has been higher than the market average.
| Beta (5Y) | 2.00 |
| 52-Week Price Change | +11.47% |
| 50-Day Moving Average | 8.17 |
| 200-Day Moving Average | 7.16 |
| Relative Strength Index (RSI) | 43.49 |
| Average Volume (20 Days) | 380,392 |
Short Selling Information
The latest short interest is 5.52 million, so 10.35% of the outstanding shares have been sold short.
| Short Interest | 5.52M |
| Short Previous Month | 5.47M |
| Short % of Shares Out | 10.35% |
| Short % of Float | 13.15% |
| Short Ratio (days to cover) | 12.63 |
Income Statement
In the last 12 months, ZVRA had revenue of $24.49 million and -$89.66 million in losses. Loss per share was -$2.11.
| Revenue | 24.49M |
| Gross Profit | 16.44M |
| Operating Income | -86.74M |
| Pretax Income | -50.87M |
| Net Income | -89.66M |
| EBITDA | -81.22M |
| EBIT | -86.74M |
| Loss Per Share | -$2.11 |
Full Income StatementBalance Sheet
The company has $89.38 million in cash and $59.93 million in debt, giving a net cash position of $29.45 million or $0.55 per share.
| Cash & Cash Equivalents | 89.38M |
| Total Debt | 59.93M |
| Net Cash | 29.45M |
| Net Cash Per Share | $0.55 |
| Equity (Book Value) | 69.77M |
| Book Value Per Share | 1.31 |
| Working Capital | 64.96M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$69.57 million and capital expenditures -$72,000, giving a free cash flow of -$69.65 million.
| Operating Cash Flow | -69.57M |
| Capital Expenditures | -72,000 |
| Free Cash Flow | -69.65M |
| FCF Per Share | -$1.30 |
Full Cash Flow StatementMargins
| Gross Margin | 67.13% |
| Operating Margin | -354.22% |
| Pretax Margin | -366.14% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ZVRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -23.73% |
| Shareholder Yield | -23.73% |
| Earnings Yield | -21.87% |
| FCF Yield | -16.99% |
Analyst Forecast
The average price target for ZVRA is $21.20, which is 176.04% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.20 |
| Price Target Difference | 176.04% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | 54.90% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on December 28, 2020. It was a reverse split with a ratio of 0.0625:1.
| Last Split Date | Dec 28, 2020 |
| Split Type | Reverse |
| Split Ratio | 0.0625:1 |
Scores
ZVRA has an Altman Z-Score of -3.21 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.21 |
| Piotroski F-Score | 2 |